Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-057204

Seres Therapeutics, Inc. · MCRB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Noubar Afeyan
Director · 10% Owner
Period of report
Jun 25, 2015
Accepted (ET)
Jun 29, 2015 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609809

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.001 par valueF4,F1Jun 26, 2015C8,822,420—A8,822,420ISee Footnote
Common Stock, $0.001 par valueF4,F2Jun 26, 2015C2,205,603—A2,205,603ISee Footnote
Common Stock, $0.001 par valueF4,F3Jun 26, 2015C599,297—A599,297ISee Footnote
Common Stock, $0.001 par valueF6holding———3,055,556ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Convertible Preferred StockF1,F4—Jun 26, 2015C6,105,362D——Common Stock6,105,3620I
Series A Convertible Preferred StockF2,F4—Jun 26, 2015C1,526,338D——Common Stock1,526,3380I
Series A Convertible Preferred StockF3,F4—Jun 26, 2015C599,297D——Common Stock599,2970I
Series A-2 Convertible Preferred StockF1,F4—Jun 26, 2015C898,877D——Common Stock898,8770I
Series A-2 Convertible Preferred StockF2,F4—Jun 26, 2015C224,719D——Common Stock224,7190I
Series B Convertible Preferred StockF1,F4—Jun 26, 2015C1,818,181D——Common Stock1,818,1810I
Series B Convertible Preferred StockF2,F4—Jun 26, 2015C454,546D——Common Stock454,5460I
Stock Option (right to buy)F5$18.00Jun 25, 2015A15,000A—Jun 24, 2025Common Stock15,00015,000I

Explanation of responses